Weight-loss drug shows promise for PCOS in new study
NCT ID NCT05965908
First seen Mar 23, 2026 · Last updated Apr 29, 2026 · Updated 4 times
Summary
This study tested whether liraglutide, a weight-loss medication, could help obese women with polycystic ovary syndrome (PCOS) lose weight and improve hormone and metabolic health. 150 women aged 20-45 took part. The goal was to see if liraglutide works better than the standard drug metformin for managing PCOS-related issues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYCYSTIC OVARY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Beni-suef university Hospital
Banī Suwayf, Beni Suweif Governorate, 62521, Egypt
Conditions
Explore the condition pages connected to this study.